{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:47:44Z","timestamp":1791496064807,"version":"4.3.4"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Hypothermia has been widely used to treat moderate to severe neonatal hypoxic\u2013ischemic encephalopathy (HIE), yet evaluating the effects of hypothermia relies on clinical neurology, neuroimaging, amplitude-integrated electroencephalography, and follow-up data on patient outcomes. Biomarkers of brain injury have been considered for estimating the effects of hypothermia. Proteins specific to the central nervous system (CNS) are components of nervous tissue, and once the CNS is damaged, these proteins are released into biofluids (cerebrospinal fluid, blood, urine, tears, saliva), and they can be used as markers of brain damage. Clinical reports have shown that CNS-specific marker proteins (CNSPs) were early expressed in biofluids after brain damage and formed unique biochemical profiles. As a result, these markers may serve as an indicator for screening brain injury in infants, monitoring disease progression, identifying damage region of brain, and assessing the efficacy of neuroprotective measures. In clinical work, we have found that there are few reports on using CNSPs as biological signals in hypothermia for neonatal HIE. The aim of this article is to review the classification, origin, biochemical composition, and physiological function of CNSPs with changes in their expression levels after hypothermia for neonatal HIE. Hopefully, this review will improve the awareness of CNSPs among pediatricians, and encourage future studies exploring the mechanisms behind the effects of hypothermia on these CNSPs, in order to reduce the adverse outcome of neonatal HIE.<\/jats:p>","DOI":"10.3389\/fped.2024.1288853","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:11:52Z","timestamp":1714738312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A biochemical feedback signal for hypothermia treatment for neonatal hypoxic\u2013ischemic encephalopathy: focusing on central nervous system proteins in biofluids"],"prefix":"10.3389","volume":"12","author":[{"given":"Hongyan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengshun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1080\/14767058.2018.1468881","article-title":"Neonatal hypoxic-ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phases of the injury","volume":"32","author":"Wang","year":"2019","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","article-title":"Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future","volume":"120","author":"Greco","year":"2020","journal-title":"Acta Neurol Beig"},{"key":"B3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum Dev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2016.05.30","article-title":"Risk factors and prognosis analysis of neonatal hypoxic- ischemic encephalopathy","volume":"31","author":"Bao","year":"2016","journal-title":"Matern Child Health Care China"},{"key":"B5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/14767058.2017.1304536","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATl): a feasibility study","volume":"31","author":"Filippi","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-444-64029-1.00010-2","article-title":"Neonatal encephalopathy and hypoxic-ischemic encephalopathy","volume":"162","author":"Gunn","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.earlhumdev.2004.10.014","article-title":"Time for a cool head-neuroprotection becomes a reality","volume":"81","author":"Wyatt","year":"2005","journal-title":"Early Hum Dev"},{"key":"B8","first-page":"214","article-title":"Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy","volume":"83","author":"Gulczy\u0144ska","year":"2012","journal-title":"Ginekol Pol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.pedneo.2016.11.001","article-title":"Therapeutic hypothermia for neonates with hypoxic ischemic encephalopathy","volume":"58","author":"Chiang","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0883073819828625","article-title":"Current practice of therapeutic hypothermia for mild hypoxic ischemic encephalopathy","volume":"34","author":"Saw","year":"2019","journal-title":"J Child Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD003311","DOI":"10.1002\/14651858.CD003311.pub3","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","volume":"31","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/archpedi.161.10.951","article-title":"Hypothermia to treat neonatal hypoxic ischemic encephalopathy: systematic review","volume":"161","author":"Shah","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fneur.2014.00273","article-title":"UCH-L1 and GFAP serum levels in neonates with hypoxic-ischemic encephalopathy: a single center pilot study","volume":"5","author":"Douglas-Escobar","year":"2014","journal-title":"Front Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S 533","DOI":"10.33549\/physiolres.933541","article-title":"Pathophysiology of perinatal hypoxic-ischemic encephalopathy-biomarkers, animal models and treatment perspectives","volume":"65","author":"Riljak","year":"2016","journal-title":"Physiol Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/siny.1999.0118","article-title":"Cooling the newborn after asphyxia-physiological and experimental background and its clinical use","volume":"5","author":"Thoresen","year":"2000","journal-title":"Semin Neonatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1096\/fj.08-116947","article-title":"Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury","volume":"23","author":"Reddy","year":"2009","journal-title":"FASEB J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0095-5108(18)30294-X","article-title":"Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals","volume":"22","author":"Palmer","year":"1995","journal-title":"Clin Pernataol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nurx.2006.01.007","article-title":"Hypothermic neuroprotection","volume":"3","author":"Gum","year":"2006","journal-title":"Neuro Rx"},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainres.2003.10.013","article-title":"Post-ischemic hypothermia-induced tissue protection and diminished apoptosis after neonatal cerebral hypoxia-ischemia","volume":"996","author":"Zhu","year":"2004","journal-title":"Brain Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1159\/000430862","article-title":"Effects of neonatal hypoxic-ischemic injury and hypothermic neuroprotection on neural progenitor cell in the mouse hippocampus","volume":"37","author":"Kwak","year":"2015","journal-title":"Dev Neurosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1515\/jpm-2017-0354","article-title":"Serum biomarkers of neuronal injury in newborns evaluated for selective head cooling: a comparative Polot study","volume":"46","author":"Patil","year":"2018","journal-title":"J Perinat Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1111\/j.1651-2227.2012.02679.x","article-title":"Effects of hypothermia on NSE and S-100 protein levels in CSF in neonataes following hypoxic\/ischaemic brain damage","volume":"101","author":"Sun","year":"2012","journal-title":"Acta Paediatr"},{"key":"B23","first-page":"23","article-title":"Effects of selective head cooling with mild hypotheimia on neuron-specific enolase in serum and behavioral neurological assessment in neonatal hypoxic-ischemic encephapathy","volume":"5","author":"Sun","year":"2014","journal-title":"Chin J Women Child Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12887-018-1013-2","article-title":"Benefits of starting hypothermia treatment within 6\u2005h vs. 6\u201312\u2005h in newborns with moderate neonatal hypoxic-ischemic encephalopathy","volume":"18","author":"Jia","year":"2018","journal-title":"BMC Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e8453","DOI":"10.1097\/MD.0000000000008453","article-title":"Relevance of urinary S100\u03b2 protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia","volume":"96","author":"Alshweki","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0234082","DOI":"10.1371\/journal.pone.0234082","article-title":"Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia","volume":"15","author":"Le\u00f3n-Lozano","year":"2020","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1055\/s-0040-1722601","article-title":"Effect of hypothermia on serum myelin basic protein and tumor necrosis factor-\u03b1 in neonatal hypoxic-ischemic encephalopathy","volume":"39","author":"Wang","year":"2022","journal-title":"Am J Perinatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpeds.2013.10.067","article-title":"Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy","volume":"164","author":"Chalak","year":"2014","journal-title":"J Pediatr"},{"key":"B29","first-page":"1193","article-title":"Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy","volume":"16","author":"Jiang","year":"2014","journal-title":"Zhangguo Dangdaierke Zazhi"},{"key":"B30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpeds.2020.06.078","article-title":"Plasma and cerebrospinal fluid candidate biomarkers of neonatal encephalopathy severity and neurodevelopmental outcomes","volume":"226","author":"Dietrick","year":"2020","journal-title":"J Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpeds.2022.07.046","article-title":"Plasma biomarkers of evolving encephalopathy and brain injury in neonates with hypoxic-ischemic encephalopathy","volume":"252","author":"Li","year":"2023","journal-title":"J Pediatr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4103\/1673-5374.217338","article-title":"Effect of erythropoietin combined with hypothermia on serum tau protein levels and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy","volume":"12","author":"Lv","year":"2017","journal-title":"Neural Regen Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s41390-021-01405-w","article-title":"Serial plasma biomarkers of brain injury in infants with neonatal encephalopathy treated with therapeutic hypothermia","volume":"90","author":"McGowan","year":"2021","journal-title":"Pediatr Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/etm.2016.3911","article-title":"SBDPs and tau proteins for diagnosis and hypothermia therapy in neonatal hypoxic ischemic encephalopathy","volume":"13","author":"Wu","year":"2017","journal-title":"Exp Ther Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pediatrneurol.2008.07.004","article-title":"Tau and s-100B proteins as biochemical markers of billrubin-induced neurotoxicity in term neonates","volume":"39","author":"Okumus","year":"2008","journal-title":"Pediatr Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cca.2015.08.021","article-title":"Neonatal hypoxic ischemic encephalopathy- related biomarkers in serum and cerebrospinal fluid","volume":"450","author":"Lv","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1161\/01.STR.0000103320.90706.35","article-title":"Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia","volume":"34","author":"Tiainen","year":"2003","journal-title":"Stroke"},{"key":"B38","first-page":"1913","article-title":"The relationship of serum neuron specific enolase, myelin base protein and serum free calcium levels in neonates with hypoxic ischemic encephalopathy","volume":"22","author":"Wang","year":"2007","journal-title":"Zhongguo Fuyou Baojian"},{"key":"B39","first-page":"343","article-title":"The changes and its significance of neuron specific enolase in the newborn hypoxic ischemic encephalopathy","volume":"12","author":"Feng","year":"1997","journal-title":"Zhongguo Shiyongerke Zazhi"},{"key":"B40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.ne.10.030187.001413","article-title":"Neuron specific enolase: a clinically useful marker of neurons and neuroendocrine cells","volume":"10","author":"Marangos","year":"1987","journal-title":"Annu Rev Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.braindev.2003.12.007","article-title":"Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathathy","volume":"26","author":"Celtik","year":"2004","journal-title":"Brain Dev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12291-011-0172-9","article-title":"Correlation of brain biomarker neuron specific enoolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke","volume":"27","author":"Bharosay","year":"2012","journal-title":"Indian Clin Biochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1203\/01.PDR.0000072518.98189.A0","article-title":"Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia","volume":"54","author":"Nagdyman","year":"2003","journal-title":"Pediatr Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","article-title":"Myelination of the nervous system: mechanisms and functions","volume":"30","author":"Nave","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.expneurol.2014.11.010","article-title":"Mild intermittent hypoxemia in neonatal mice causes permanent neurofunctional deficit and white matter hypomyelination","volume":"264","author":"Juliano","year":"2015","journal-title":"Exp Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1523\/JNEUROSCI.3955-08.2009","article-title":"Phosphatidylinositol 4,5-bisphosphate-dependent interaction of myelin basic protein with the plasma membranein oligodendroglial cells and its rapid perturbation by elevate calcium","volume":"29","author":"Nawaz","year":"2009","journal-title":"J Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1471-4159.1988.tb01153.x","article-title":"Expression and localization of myelin basic protein in oligodendrocytes and transfected fibroblasts","volume":"51","author":"Barbarese","year":"1988","journal-title":"J Neurochem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-0404.1983.tb04841.x","article-title":"CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies","volume":"68","author":"Waigt","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"B49","first-page":"5","article-title":"Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness","volume":"24","author":"Davies","year":"1987","journal-title":"Clin Exp Neurol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1203\/00006450-200206000-00019","article-title":"White matter injury after cerebral ischemia in ovine fetuses","volume":"51","author":"Petersson","year":"2002","journal-title":"Pediatr Res"},{"key":"B51","first-page":"63","article-title":"Serum level of mylin basic protein in hypoxic-ischemic encephathy neonates","volume":"45","author":"Hu","year":"2009","journal-title":"Acta Academiae Medicin QingDao Universitis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12028-012-9767-0","article-title":"Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia","volume":"17","author":"Su","year":"2012","journal-title":"Neurocrit Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/pr.2017.75","article-title":"Effects of therapeutic hypothermia on white matter injury from murine neonatal hypoxia-ischemia","volume":"82","author":"Koo","year":"2017","journal-title":"Pediatr Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41390-019-0475-8","article-title":"Protection of axonal integrity with 48 or 72 h of cerebral hypothermia in near-term fetal sheep","volume":"88","author":"Zhou","year":"2020","journal-title":"Pediatr Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"25178","DOI":"10.1038\/srep25178","article-title":"Extending the duration of hypothermia does not further improve white matter protection after ischemia in term-equivalent fetal sheep","volume":"6","author":"Davidson","year":"2016","journal-title":"Sci Rep"},{"key":"B56","first-page":"198","article-title":"S100 protein family and its application in clinical practice","volume":"12","author":"Sedaghat","year":"2008","journal-title":"Hippokratia"},{"key":"B57","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1373\/49.6.967","article-title":"Pediatric concentrations of S100\u03b2 protein in blood: age-and sex-related changes","volume":"49","author":"Gazzolo","year":"2003","journal-title":"Clin Chem"},{"key":"B58","first-page":"564","article-title":"Urinary S100\u03b2 protein and lactate\/creatinine ratio measurements:a tool for the early identification of neonatal hypoxic-ischemic encephalopathy","volume":"43","author":"Liu","year":"2005","journal-title":"Zhonghua Erke Zazhi"},{"key":"B59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","article-title":"Serum S100\u03b2 as a possible marker of blood-brain barrier disruption","volume":"94","author":"Kapural","year":"2002","journal-title":"Brain Res"},{"key":"B60","first-page":"767","article-title":"S-100\u03b2 protein in the neonatal hypoxic ischemic encephalopathy in the clinical application","volume":"2","author":"Chen","year":"2009","journal-title":"J Med Theor Pract"},{"key":"B61","first-page":"705","article-title":"Effects of erythropoietin on serum NSE and S-100\u03b2 levels in neonates with hypoxic ischemic encephalopathy","volume":"16","author":"Pei","year":"2014","journal-title":"Zhongguo Dangdaierke Zazhi"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/archpedi.157.12.1163","article-title":"Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants","volume":"157","author":"Gazzolo","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0115194","DOI":"10.1371\/journal.pone.0115194","article-title":"Neurological abnormalities in full-term asphyxiated newborns and salivary S100\u03b2 testing: the\u201c cooperative multitask against brain injury of neonates\u201d(CoMBINe) international study","volume":"10","author":"Gazzolo","year":"2015","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jpeds.2012.02.047","article-title":"Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia","volume":"161","author":"Massaro","year":"2012","journal-title":"J Pediatr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12519-023-00698-7","article-title":"Biomarkers of hypoxic-ischemic encephalopathy: a systematic review","volume":"19","author":"Caramelo","year":"2023","journal-title":"World J Pediatr"},{"key":"B66","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2010.01.010","article-title":"Morphological changes in white matter astrocytes in response to hypoxia\/ischemia in the neonatal pig","volume":"1319","author":"Sulliva","year":"2010","journal-title":"Brain Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"251.e1","DOI":"10.1016\/j.ajog.2011.06.025","article-title":"Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling","volume":"205","author":"Ennen","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2741\/s45","article-title":"Biochemical markers of perinatal brain damage","volume":"2","author":"Florio","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fneur.2015.00264","article-title":"Glial fibrillary acidic protein is not an early marker of injury in perinatal asphyxia and hypoxic-ischemic encephalopathy","volume":"6","author":"Looney","year":"2015","journal-title":"Front Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res Rev"},{"key":"B71","first-page":"317","article-title":"Changes of serum tau, GFAP, TNF-\u03b1 and malonaldehyde after blast-related traumatic brain injury","volume":"17","author":"Liu","year":"2014","journal-title":"Chin J Traumatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.braindev.2013.10.007","article-title":"Serum tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia","volume":"36","author":"Takahashi","year":"2014","journal-title":"Brain Dev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.7754\/Clin.Lab.2017.170103","article-title":"Predictive value of neurodevelopmental outcome and serum tau protein level in neonates with hypoxic-ischemic encephalopathy","volume":"63","author":"Lv","year":"2017","journal-title":"Clin Lab"},{"key":"B74","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12013-012-9478-3","article-title":"Dynamic changes of cerebral-specific proteins in full-term newborns with hypoxic-ischemic encephalopathy","volume":"66","author":"Liu","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"B75","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0006-8993(83)90241-X","article-title":"PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells","volume":"278","author":"Thompson","year":"1983","journal-title":"Brain Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-3806(94)00217-N","article-title":"PGP 9.5, an ubiquitin C-terminal hydrolase: pauem of mRNA and protein expression during neural development in the mouse","volume":"85","author":"Schofield","year":"1995","journal-title":"Brain Res Dev Brain Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1089\/neu.2010.1564","article-title":"Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids","volume":"28","author":"Brophy","year":"2011","journal-title":"J Neurotrauma"},{"key":"B78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1939-1676.2010.0645.x","article-title":"Biomarkers of brain injury in foals with hypoxic-ischemic encephalopathy","volume":"25","author":"Ringger","year":"2011","journal-title":"J Vet Intern Med"},{"key":"B79","first-page":"13","article-title":"Effect of hypothermia on the expression level of serum ubiqutin carboxy-terminal hydrolaseL1 and hypoxia \u2013induced factor-1a and neurodevelopmental outcomes in neonatal hypoxic-ischemic encephalopathy","volume":"12","author":"Lv","year":"2024","journal-title":"J Dev Med (Electronic Version)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1203\/01.PDR.0000061588.39652.26","article-title":"Changes in neurotrophin levels in umbilical cord blood from infant with different gestational age and clinical conditions","volume":"53","author":"Chouthai","year":"2003","journal-title":"Pediatr Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3923\/pjbs.2009.1498.1504","article-title":"Gord blood brain derived neurotrophic factor: diagnostic and prognostic marker in full-term newborns with perinatal asphyxia","volume":"12","author":"Imam","year":"2009","journal-title":"Pak J Biol Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000454949","article-title":"Therapeutic hypothermia provides variable protection against behavioral deficits after neonatal hypoxia-ischemia: a potential role for brain-derived neurotrophic factor","volume":"39","author":"Diaz","year":"2017","journal-title":"Dev Neurosci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1152\/jn.00398.2021","article-title":"Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis","volume":"127","author":"Heckler","year":"2022","journal-title":"J Neurophysiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-022-00328-8","article-title":"Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson\u2019s disease dementia","volume":"12","author":"Frigerio","year":"2023","journal-title":"Transl Neurodegener"},{"key":"B85","first-page":"9","article-title":"The change and clinical significance of serum aquaporin-4 and pNF-H in patients with moderate and severe traumatic brain injury","volume":"13","author":"Li","year":"2015","journal-title":"Chin Foreign Med Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.08.252","article-title":"Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury","volume":"336","author":"Shaw","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/neu.2007.0488","article-title":"The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury","volume":"25","author":"Anderson","year":"2008","journal-title":"J Neurotrauma"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1002\/jnr.21803","article-title":"Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis","volume":"86","author":"Gresle","year":"2008","journal-title":"J Neurosci Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neulet.2007.02.053","article-title":"Plasma neurofilament heavy chain levels in huntington\u2019s disease","volume":"417","author":"Wild","year":"2007","journal-title":"Neurosci Lett"},{"key":"B90","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1179\/016164107X240080","article-title":"CSF biomarkers for improved prognostic accuracy in acute CNS disease","volume":"29","author":"Petzold","year":"2007","journal-title":"Neurol Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"584743","DOI":"10.3389\/fnagi.2020.584743","article-title":"Neurogranin: a potential biomarker of neurological and mental diseases","volume":"12","author":"Xiang","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1523\/JNEUROSCI.10-12-03782.1990","article-title":"Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate","volume":"10","author":"Represa","year":"1990","journal-title":"J Neurosci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1038\/emboj.2009.236","article-title":"Neurogranin enhances synaptic strength through its interaction with calmodulin","volume":"28","author":"Zhong","year":"2009","journal-title":"EMBO J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1007\/s12035-019-1593-3","article-title":"Neurogranin expression is regulated by synaptic activity and promotes synaptogenesis in cultured hippocampal neurons","volume":"56","author":"Garrido-Garc\u00eda","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fneur.2017.00641","article-title":"Derivation of a three biomarker panel to improve diagnosis in patients with mild traumatic brain injury","volume":"8","author":"Peacock","year":"","journal-title":"Front Neurol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"106889","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106889","article-title":"The diagnostic and prognostic value of serum neurogranin in acute ischemic stroke","volume":"32","author":"Ku\u015fdo\u011fan","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jad.2016.01.034","article-title":"Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population","volume":"194","author":"Wen","year":"2016","journal-title":"J Affect Disord"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1288853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:13:30Z","timestamp":1714738410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1288853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":97,"alternative-id":["10.3389\/fped.2024.1288853"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1288853","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"article-number":"1288853"}}